All Articles

JFrog's inclusion in the Russell 3000 isn't just a corporate win; it's a signal of the market's new respect for the software supply chain's vital role.

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

As a key architect of its global manufacturing retires, Alliance Laundry bets on financial discipline and investor savvy to drive its next growth cycle.

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

Frazier Healthcare Partners adds Milton Boyer as an EIR, signaling a strategic push into the complex pharmaceutical manufacturing sector with a proven operator.

Despite massive security investments, known vulnerabilities are wreaking havoc. A new report reveals why AI demands a shift from pre-production to runtime defense.

As AI and cyber risks escalate, the new 'Chief Trust Officer' role is emerging. HITRUST's appointment of a veteran leader signals a major shift for all.

TELUS's #StandWithOwners returns, but its new focus on a year-round community reveals a deeper strategy: building an ecosystem, not just running a contest.

An analysis of 89 school districts reveals a new data-driven playbook for reducing chronic absenteeism, with major implications for EdTech and human capital.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

A new partnership between SoundExchange and IFPI automates a critical piece of music's data puzzle, promising fairer pay and less bureaucracy for indie artists.

The 'better-for-you' brand is betting on a booming peanut butter market with its first non-chocolate snack, a strategic move backed by deep market data.

At InfoComm 2026, Taiwan isn't just selling hardware. It's unveiling a national strategy to dominate the future of AI-driven enterprise technology.

A novel probiotic, sourced from an elite athlete's gut, has navigated the FDA's complex regulatory maze, signaling a major shift for the entire industry.

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

As Recursion heads to a key investor conference, it must prove its AI-powered drug discovery platform can deliver financial results, not just scientific promise.

A new partnership is democratizing science for wellness brands, making it faster and cheaper to prove their final products work and earn customer trust.

Penn Highlands Healthcare is offering up to $65K in loan repayment to build its workforce. Is this the new blueprint for solving talent shortages?

Hyundai's May sales reveal a masterclass in market navigation, with a 90% hybrid boom offsetting EV nuances and signaling a shrewd strategic pivot.

As XYZ Registry celebrates 10 million domains, a deeper look reveals how its flagship .xyz extension evolved from a novelty into a strategic choice for tech's new guard.